Idorsia And Viatris Update Collaboration For Selatogrel And Cenerimod

Reuters
26 Feb
Feb 26 (Reuters) - IDORSIA LTD ::
*IDORSIA AND VIATRIS UPDATE THEIR COLLABORATION FOR SELATOGREL AND CENERIMOD
*VIATRIS POTENTIAL REGULATORY AND SALES MILESTONES PAYMENTS TO IDORSIA REDUCED BY USD 250 MILLION
*IDORSIA'S CONTRIBUTION TO DEVELOPMENT COSTS REDUCED BY USD 100 MILLION
*AGREED ROYALTIES ON FUTURE SALES REMAIN UNCHANGED

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 26-FEB-202505:55:00.043 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10